Roth Capital notes Sanuwave Health (SNWV) announced that its UltraMIST product line had been added to Healogics Wound Care Supply’s group purchasing organization, Healogics iSupply. The collaboration with iSupply makes UltraMIST an option for iSupply members, which include wound care centers, home health agencies, and skilled nursing facilities. Sanuwave Health plans to roll out UltraMIST to iSupply members at initial locations by the end of 2025. The firm views the news as highly favorable given Healogics partners with over 600 wound care centers across the U.S. Roth has a Buy rating on the shares with a price target of $53.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNWV:
